Pfizer Vows Appeal After India Revokes Sutent Patent
Pfizer Inc. said Friday that it would fight a ruling by the Indian Patent Office revoking a local patent for its cancer treatment drug Sutent, the latest in a string of...To view the full article, register now.
Already a subscriber? Click here to view full article